The interplay between cortisol, inflammation, and disease underscores the need for effective stress management to enhance ...

Location: Room J-L. Reverdin (CMU) Date and Time: Friday, 28 March, 12:15–13:15 Title: Circadian variation in chronic inflammatory disease, a role for regulatory T cells.

High-parameter flow cytometry of peripheral blood mononuclear cells enabled physicians to treat recalcitrant erythroderma in ...

IN8bio (INAB) unveiled INB-600, its next generation gammadelta T cell-based TCE platform. It is designed to address one of the biggest ...

Proprietary platform represents the first known approach capable of sustained γδ T cell expansion, eliminating target cells ...

Proprietary platform represents the first known approach capable of sustained gamma-delta T cell expansion, eliminating target cells with robust potencyINB-619, a next generation gamma-delta TCE targe ...

IMNN-001 is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables cell transfection followed by persistent, local secretion of the IL-12 protein. IL-12 is one of the most ...

Cytokines are secreted ... signaling thresholds across cell populations. For example, IL-2 partial agonists can selectively expand CD4+ regulatory T cells (Treg cells) (blue) over effector CD8 ...

Porter has played a pivotal role in advancing the field, including pioneering work in CAR T-cell therapy. Dr. Porter has been deeply involved with ASTCT, previously serving as the Society's ...

The other authors report no conflicts. The study was supported in part by grants from the National Heart, Lung, and Blood Institute 91 (HL144552, HL157975-01A1, and HL164016-01A1) and Answering T.T.P.